Week in Review: Abbisko Raises $70 Million To Develop Cancer Drug Candidates
March 28, 2020 at 16:03 PM EDT
Shanghai Abbisko Therapeutics raised $70 million in a Series C financing to develop its portfolio of small molecule targeted oncology and immuno-oncology candidates.
